Summary
Liver repopulation by transplanted hepatocytes is a promising approach for many inborn errors of metabolism. In this review, examples of liver repopulation in animals and the implications of these models for clinical cell transplantation will be discussed.
Similar content being viewed by others
References
Braun KM, Degen JL, Sandgren EP (2000) Hepatocyte transplantation in a model of toxin-induced liver disease: variable therapeutic effect during replacement of damaged parenchyma by donor cells. Nat Med 6: 320–326.
Bucher NLR, Swaffield MN (1964) The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res 240: 1611–1625.
Busuttil RW, Klintmalm GB (1996) In: Transplantation of the Liver, 1st ed., Philadelphia: Saunders.
Dandri M, Burda MR, Torok E, etal (2001) Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 33: 981–988.
Dandri M, Burda MR, Zuckerman DM, etal (2005) Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes. J Hepatol 42: 54–60.
De Vree JM, Ottenhoff R, Bosma PJ, Smith AJ, Aten J, Oude Elferink RP (2000) Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720–1730.
Desagher S, Osen-Sand A, Montessuit S, etal (2001) Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cells 8: 601–611.
Fox IJ, Chowdhury JR, Kaufman SS, etal (1998) Treatment of the Crigler—Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338: 1422–1426.
Grisham JW (1962) A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver: Autoradiography with thymidine-H3. Cancer Res 22: 842–849.
Grompe M, Al-Dhalimy M, Finegold M, etal (1993) Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev 7: 2298–2307.
Grompe M, Lindstedt S, Al-Dhalimy M, etal (1995) Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I. Nat Genet 10: 453–460.
Grossman M, Raper SE, Kozarsky K, etal (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet 6: 335–341.
Guha C, Sharma A, Gupta S, etal (1999) Amelioration of radiation-induced liver damage in partially hepatectomized rats by hepatocyte transplantation. Cancer Res 59: 5871–5874.
Guha C, Parashar B, Deb NJ, etal (2002) Normal hepatocytes correct serum bilirubin after repopulation of Gunn rat liver subjected to irradiation/partial resection. Hepatology 36: 354–362.
Gupta S (2002) Hepatocyte transplantation. J Gastroenterol Hepatol 17(Supplement 3): S287–S293.
Jamal HZ, Weglarz TC, Sandgren EP (2000) Cryopreserved mouse hepatocytes retain regenerative capacity in vivo. Gastroenterology 118: 390–394.
Kay MA, Woo SL (1994) Gene therapy for metabolic disorders. Trends Genet 10: 253–257.
Kvittingen EA, Rootwelt H, Brandtzaeg P, Bergan A, Berger R (1993) Hereditary tyrosinemia type I. Self-induced correction of the fumarylacetoacetase defect. J Clin Invest 91: 1816–1821.
Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P (1994) Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest 94: 1657–1661.
Laconi E, Oren R, Mukhopadhyay DK, etal (1998) Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol 153: 319–329.
Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 340: 813–817.
Meuleman P, Libbrecht L, De Vos R, etal (2005) Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41: 847–856.
Mignon A, Guidotti JE, Mitchell C, etal (1998) Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes. Nat Med 4: 1185–1188.
Mitchell C, Mignon A, Guidotti JE, etal (2000) Therapeutic liver repopulation in a mouse model of hypercholesterolemia. Hum Mol Genet 9: 1597–1602.
Oren R, Dabeva MD, Petkov PM, Hurston E, Laconi E, Shafritz DA (1999) Restoration of serum albumin levels in nagase analbuminemic rats by hepatocyte transplantation. Hepatology 29: 75–81.
Overturf K, Al-Dhalimy M, Tanguay R, etal (1996) Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet 12: 266–273.
Rajvanshi P, Kerr A, Bhargava KK, Burk RD, Gupta S (1996) Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology 111: 1092–1102.
Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL (1994) Replacement of diseased mouse liver by hepatic cell transplantation. Science 263: 1149–1152.
Rhim JA, Sandgren EP, Palmiter RD, Brinster RL (1995) Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA 92: 4942–4946.
Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, JL (1991) Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 66: 245–256.
Shneider BL (2002) Pediatric liver transplantation in metabolic disease: clinical decision making. Pediatr Transplant 6: 25–29.
Vajro P, Strisciuglio P, Houssin D, etal (1993) Correction of phenylketonuria after liver transplantation in a child with cirrhosis. N Engl J Med 329: 363.
Vogel A, van Den Berg IE, Al-Dhalimy M, etal (2004) Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death. Hepatology 39: 433–443.
Vogel A, Aslan JE, Willenbring H, etal (2006) Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases. Gastroenterology 130: 104–119
Vrancken Peeters MJ, Patijn GA, Lieber A, Perkins J, Kay MA (1997) Expansion of donor hepatocytes after recombinant adenovirus-induced liver regeneration in mice. Hepatology 25: 884–888.
Weglarz TC, Degen JL, Sandgren EP (2000) Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes. Am J Pathol 157: 1963–1974.
Whitington PF, Alonso EM, Boyle JT, etal (1998) Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 21(Supplement 1): 112–118.
Witek RP, Fisher SH, Petersen BE (2005) Monocrotaline, an alternative to retrorsine-based hepatocyte transplantation in rodents. Cell Transplant 14: 41–47.
Yazigi NA, Carrick TL, Bucuvalas JC, Schmidt CS, Balistreri WF, Bezerra JA (1997) Expansion of transplanted hepatocytes during liver regeneration. Transplantation 64: 816–820.
Yoshida Y, Tokusashi Y, Lee GH, Ogawa K (1996) Intrahepatic transplantation of normal hepatocytes prevents Wilson′s disease in Long-Evans cinnamon rats. Gastroenterology 111: 1654–1660.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Jean-Marie Saudubray
Competing interests: None declared
Rights and permissions
About this article
Cite this article
Grompe, M. Principles of therapeutic liver repopulation. J Inherit Metab Dis 29, 421–425 (2006). https://doi.org/10.1007/s10545-006-0311-2
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0311-2